Perspective: Nonalcoholic fatty liver disease and cardiovascular risk

Current Opinion in Lipidology

Volumn 24, Issue 1, 2013, Pages 1-3

  Nestel, Paul J ^a   Mensink, Ronald P ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; DIETARY INTAKE; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIVER BIOPSY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NUTRITIONAL COUNSELING; OBESITY; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PULSE WAVE; REVIEW;

ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; FATTY LIVER; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN RESISTANCE; LIVER; METABOLIC SYNDROME X; PREVALENCE; RISK FACTORS;

EID: 84872839412     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32835c0834     Document Type: Review

References (20)

1. Mensink RP, Plat J, Schrauwen P. Diet and nonalcoholic liver disease. Curr Opin Lipidol 2008; 19:25-29.
2. Bhatia LS, Curzen NP, Calder PC, et al. Nonalcoholic fatty liver disease: a new and important cardiovascular factor. Eur Heart J 2012; 33:1190-1200.
3. Huang Y, Yufang B, Xu M, et al. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arterioscler Thromb Vasc Biol 2012; 32:2321-2326.
4. Ruttmann E, Brant LJ, Concin H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality. Circulation 2005; 112:2130-2137.
5. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143:722-728.
6. Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events in type2 diabetes patients. Diabetes 2005; 54:3541-3546.
7. Thakur ML, Sharma S, Kumar A, et al. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis 2012; 223:507-511.
8. Angelico F, Del Ben M, Conti R, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005; 90:1578-1582.
9. Nazare J-A, Smith JD, Borel A-L, et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-abdominal adiposity and Its Relationship with Cardiometabolic Risk/Intra-abdominal Adiposity. Am J Clin Nutr 2012; 96:714-726.
10. Fan JG, Li F, Cai XB, et al. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J Gastroenterol Hepatol 2007; 22:1086-1091.
11. Vozorova B, Stefan N, Lindsay RS, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of diabetes. Diabetes 2002; 51:1889-1895.
12. Nanniperi M, Gonzales C, Baldi S, et al. Liver enzymes, the metabolic syndrome and incident diabetes. The Mexico City Diabetes Study. Diabetes Care 2005; 28:1757-1762.
13. Straznicky NE, Lambert EA, Grima MT, et al. The effects of weight loss with or without aerobic exercise training on liver enzymes in obese metabolic syndrome subjects. Diabetes Obes Metab 2012; 14:139-148.
14. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and nonalcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histological improvement. Obes Surg 2006; 16:1278-1286.
15. Sevastianova K, Santos A, Kotronen A, et al. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr 2012; 96:727-734.
16. Johnson NA, Sachinwalla T, Walton DW, et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009; 50:1105-1112.
17. Carvalhana S, Machado MV, Cortez-Pinto H. Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2012; 15:468-473.
18. Mouzaki M, Allard JP. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J Clin Gastroenterol 2012; 46:457-467.
19. De Wit NJ, Afman LA, Mensink M, Mu? ller M. Phenotyping the effect of diet on nonalcoholic fatty liver disease. J Hepatol 2012 [Epub ahead of print].
20. Vos MB, Colvin R, Belt P, et al. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr 2012; 54:90-96.